An anti-inflammatory agent can be prepared using, as an active ingredient, milk-derived exosomes, e.g., an exosome fraction which is produced by removing a lipid fraction, a cell fraction and a casein fraction from milk to prepare a whey fraction and then collecting the exosome fraction from the whey fraction.